| Answer | % Correct |
|---|---|
| Adrenaline | 61%
|
| Insulin | 59%
|
| Growth hormone | 53%
|
| Dopamine | 47%
|
| Oxytocin | 46%
|
| Antidiuretic hormone | 43%
|
| Follicle stimulating hormone | 43%
|
| Glucagon | 42%
|
| Noradrenaline | 39%
|
| Thyroid stimulating hormone | 39%
|
| Melatonin | 37%
|
| Prolactin | 28%
|
| Thyroxine | 28%
|
| Calcitonin | 25%
|
| Gastrin | 23%
|
| Luteinizing hormone | 23%
|
| Gonadotropin releasing hormone | 22%
|
| Ghrelin | 20%
|
| Growth hormone releasing hormone | 19%
|
| Corticotropin releasing hormone | 18%
|
| Renin | 18%
|
| Adrenocorticotropic hormone | 16%
|
| Leptin | 16%
|
| Parathyroid hormone | 16%
|
| Secretin | 16%
|
| Somatostatin | 16%
|
| Thyrotropin releasing hormone | 16%
|
| Angiotensin | 15%
|
| Human chorionic gonadotropin | 14%
|
| Triiodothyronine | 14%
|
| Cholecystokinin | 13%
|
| Inhibin | 11%
|
| Atrial natriuretic peptide | 10%
|
| Erythropoietin | 10%
|
| Melanocyte stimulating hormone | 10%
|
| Orexin | 10%
|
| Prolactin releasing hormone | 10%
|
| Relaxin | 9%
|
| Insulin-like growth factor | 8%
|
| Lipotropin | 8%
|
| Prostaglandins | 6%
|
| Enkephalin | 6%
|
| Glucagon-like peptide | 6%
|
| Motilin | 6%
|
| Amylin | 5%
|
| Anti-Müllerian hormone | 5%
|
| Human placental lactogen | 5%
|
| Uroguanylin | 5%
|
| Brain natriuretic peptide | 4%
|
| Leukotrienes | 4%
|
| Osteocalcin | 4%
|
| Prostacyclin | 4%
|
| Retention of water | 4%
|
| Thrombopoietin | 4%
|
| Thromboxane | 4%
|
| Vasoactive intestinal peptide | 4%
|
| ACTH release | 3%
|
| Adiponectin | 3%
|
| Breast milk release, vaginal contraction | 3%
|
| Cortistatin | 3%
|
| FSH, LH release | 3%
|
| GH release | 3%
|
| Guanylin | 3%
|
| Hepcidin | 3%
|
| Pancreatic polypeptide | 3%
|
| Prolactin release | 3%
|
| Sleep-wake cycle | 3%
|
| TSH, prolactin release | 3%
|
| Wakefulness | 3%
|
| Appetite | 1%
|
| Endothelin | 1%
|
| Fight-or-flight reaction | 1%
|
| Galanin | 1%
|
| Glucose intake | 1%
|
| Ovulation/testosterone production | 1%
|
| Vasodilation | 1%
|
| Action potential inhibition | 0%
|
| Bicarbonate secretion | 0%
|
| Ca2+ bone construction | 0%
|
| Corpus luteum maintenance | 0%
|
| Corticosteroid synthesis | 0%
|
| Decrease of appetite | 0%
|
| Depression of neuronal activity | 0%
|
| Digestion inhibition | 0%
|
| Erythrocyte production | 0%
|
| ECL cell stimulation | 0%
|
| Fatty acid and glucose regulation | 0%
|
| FSH production inhibition | 0%
|
| Gastric acid secretion | 0%
|
| Gastric activity stimulation | 0%
|
| Gastric inhibitory polypeptide | 0%
|
| GH, TRH, gut hormones release inhibition | 0%
|
| Glycogenolysis, gluconeogenesis | 0%
|
| Graafian follicle maturation/spermatogenesis | 0%
|
| Growth and cell reproduction | 0%
|
| Heart contractility, vasodilation | 0%
|
| Increased metabolism | 0%
|
| Insulin, IGF production | 0%
|
| Insulin-like effects | 0%
|
| Insulin secretion | 0%
|
| Insulin synthesis and release | 0%
|
| Intestinal water transport regulation | 0%
|
| Iron export inhibition | 0%
|
| Lipolysis | 0%
|
| Melanogenesis | 0%
|
| Milk production | 0%
|
| Muscle function | 0%
|
| PAC activating peptide | 0%
|
| Pain regulation | 0%
|
| Pancreatic secretion regulation | 0%
|
| Platelet production | 0%
|
| Prolactin and TRH release inhibition | 0%
|
| Prolactin release inhibition | 0%
|
| RAS activation | 0%
|
| Reducing blood pressure | 0%
|
| Release of bile, pancreatic enzymes | 0%
|
| Release of Ca2+ from bone | 0%
|
| Renal water transport regulation | 0%
|
| Smooth muscle contraction | 0%
|
| Sodium excretion increase | 0%
|
| T3, T4 secretion | 0%
|
| Unclear | 0%
|
| Vascular permeability increase | 0%
|
| Vasoconstriction, aldosterone release | 0%
|
| Vasoconstriction, platelet aggregation | 0%
|
| Vasodilation, platelet inhibition | 0%
|